2008
DOI: 10.1038/ncponc1023
|View full text |Cite
|
Sign up to set email alerts
|

Improved outcome with multimodality therapy in primary cardiac angiosarcoma

Abstract: Neoadjuvant and adjuvant chemotherapy with doxorubicin and complete surgical resection of the tumor with reconstruction of the right atrium using bovine pericardium.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0
3

Year Published

2009
2009
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(22 citation statements)
references
References 7 publications
(4 reference statements)
0
19
0
3
Order By: Relevance
“…9) Systemic symptoms only, such as weight loss, fever, night sweats, and chills occur in approximately 10% of these patients in the absence of cardiac symptoms. 10) These nonspecific symptoms, the rarity of the disease, and its rapid progression, with tumor metastases to multiple organs, are responsible for the late diagnosis and poor prognosis. Therefore, it is important to make a diagnosis at early stages of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…9) Systemic symptoms only, such as weight loss, fever, night sweats, and chills occur in approximately 10% of these patients in the absence of cardiac symptoms. 10) These nonspecific symptoms, the rarity of the disease, and its rapid progression, with tumor metastases to multiple organs, are responsible for the late diagnosis and poor prognosis. Therefore, it is important to make a diagnosis at early stages of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiac transplantation has been performed, but the use of immunosuppressant drugs is a limiting factor because it predisposes to tumor recurrence and metastases (11). The appropriate evidence-based treatment guidelines are still not established because of the rarity of the tumor, although multimodality palliative therapy with surgery and chemotherapy may be useful (12). In the present case, metastasis had already exsited, complete surgical excision was not achieved and no other therapy modality was used, so survival time was limited.…”
Section: Discussionmentioning
confidence: 93%
“…If surgical resection is not possible, median survival is approximately 6 months (7,17). In one case report of a metastatic patient, multimodality palliative treatment with neoadjuvant and adjuvant chemotherapy and surgery improved survival (18). The patient presented herein had minimal symptomatic disease for about 8 months with multimodality treatment including incomplete resection and chemotherapy.…”
Section: Discussionmentioning
confidence: 99%